Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations
Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Respiratory Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: COPD exacerbations, salmeterol/fluticasone, salmeterol, inhaled corticosteroids, beta2-adrenergic agonists, combination therapy, pneumonia, oral corticosteroids, exacerbation prevention, maintenance therapy, adverse events, long-term treatment outcomes, COPD severity, hospitalization risk, antibiotic use, FEV1 decline, lung function decline
Open Access status: bronze
Funder: GlaxoSmithKline
OpenAlex ID: W2088797046
